16 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 16 of 16 clinical reviews.
Is it safe to take Addyi (flibanserin) with acetaminophen? A guide covering CYP3A4 metabolism, hepatic risk, CNS effects, dose limits, and monitoring recommendations.
Board-reviewed clinical guide to taking Addyi (flibanserin) with metformin. Covers CYP metabolism, severity rating, monitoring parameters, dose adjustments, and patient counseling.
Can you take Addyi (flibanserin) with progesterone HRT? Learn about the sedation overlap, CYP3A4 considerations, monitoring protocols, and dose-adjustment guidance backed by FDA labeling and primary literature.
Clinical analysis of the flibanserin-rivaroxaban drug interaction, including CYP3A4 mechanism, severity rating, monitoring parameters, and dose-adjustment strategies for prescribers and patients.
A clinician-level review of the flibanserin (Addyi) and apixaban drug interaction, covering CYP3A4 and P-glycoprotein mechanisms, bleeding risk, severity classification, monitoring parameters, and patient counseling points.
A guide to the flibanserin, bupropion drug interaction, covering CYP2D6 inhibition, blood-level changes, side-effect risks, dose adjustments, and monitoring protocols.
Can you take Addyi (flibanserin) with estradiol HRT? A guide covering CYP3A4 pharmacokinetics, cardiovascular overlap risks, monitoring protocols, and dose-adjustment strategies.
Can you take Addyi (flibanserin) with gabapentin? Review the pharmacologic interaction profile, CNS depression risk, dose adjustments, and monitoring recommendations backed by FDA labeling and primary literature.
Clinical review of the flibanserin (Addyi) and hormonal contraceptives interaction, including CYP3A4 pharmacokinetics, FDA label data, safety profile, and prescriber guidance.
Can you take Addyi (flibanserin) with pregabalin? Learn about the pharmacodynamic interaction, CNS depression risks, severity rating, dose adjustments, and monitoring recommendations backed by FDA labeling and clinical evidence.
Flibanserin (Addyi) and simvastatin share the CYP3A4 metabolic pathway, raising the risk of increased statin exposure and side effects. Learn the mechanism, severity, monitoring, and dose-adjustment guidance.
Can Addyi be taken with venlafaxine or duloxetine? A current-label review of what is known, what has not been studied, and which interaction risks matter.
Flibanserin (Addyi) combined with SSRIs like sertraline or escitalopram raises serotonin syndrome risk and may worsen CNS depression. Learn the mechanism, severity rating, monitoring protocol, and safer alternatives from HealthRX.com clinicians.
Evidence-based guide to the flibanserin-benzodiazepine interaction covering CNS depression risk, CYP3A4 pharmacokinetics, dose adjustments, and patient counseling, with an evidence-status breakdown of what is established versus plausible.
Detailed clinical guide on the interaction between flibanserin (Addyi) and opioids including oxycodone, hydrocodone, and tramadol. Covers CNS depression risk, CYP metabolism, dose adjustments, and monitoring.
Board-certified guide to the flibanserin and warfarin drug interaction, covering CYP metabolism, INR monitoring, clinical trial data, and practical patient counseling.